Search
Search Results
##search.searchResults.foundPlural##
-
The Outcome of Six Patients with COVID-19 Infection and Multiple Myeloma. A Case Series and Literature Review COVID-19 in Multiple Myeloma patients
886PDF: 324HTML: 162 -
SICKLE CELL ANAEMIA AND MALARIA
11028PDF: 6776HTML: 23774Figures Malaria and SCK: 178 -
-
TDT Positive High-Grade Lymphoma with Myc, BCL2 And BCL6 Rearrangements: a Review of Diagnosis and Treatment TDT POSITIVE HIGH-GRADE LYMPHOMA WITH MYC, BCL2 AND BCL6 REARRANGEMENTS.
1568PDF: 697HTML: 446 -
MYELODYSPLASTIC SYNDROMES AND IRON CHELATION THERAPY
3296PDF: 1245HTML: 1845Fig.1: 177Fig. 2: 185 -
Microangiopathic Anemia of Acute Brucellosis – is it a True TTP?
1113PDF: 754HTML: 1753 -
EFFICACY OF VENETOCLAX COMBINED WITH AZACITIDINE IN ELDERLY PATIENTS WITH RELAPSED ACUTE MYELOID LEUKEMIA
1311PDF: 684Suppl. Files: 294Html: 117 -
JUSTIFICATION OF UNIVERSAL IRON SUPPLEMENTATION FOR INFANTS 6-12 MONTHS IN REGIONS WITH A HIGH PREVALENCE OF THALASSEMIA Iron Supplementation for Infants 6-12 months in Regions with a High Prevalence of Thalassemia
1921PDF: 570Suppl. Files: 263HTML: 149 -
POST-TRANSPLANT LYMPHOPROLIFERATIVE DISORDERS: ROLE OF VIRAL INFECTION, GENETIC LESIONS AND ANTIGEN STIMULATION IN THE PATHOGENESIS OF THE DISEASE
1190PDF: 449HTML: 18539Figure 1: 151Figure 2: 135Figure 3: 152Figure 4: 185Figure 5: 153 -
DISTRIBUTION OF DNA DAMAGE REPAIR GENE POLYMORPHISM hOGG1, XRCC1 and p53 AMONG SICKLE CELL DISEASE PATIENTS IN INDIA
1445PDF: 755HTML: 1458Table Genotype and allele frequencies of hOGG1 codon 326 Ser>Cys and p53 72Arg>Pro polymorphisms among SCD patients and control group: 159 -
MOLECULAR PATHOGENESIS OF SECONDARY ACUTE PROMYELOCYTIC LEUKEMIA
2705PDF: 810HTML: 6491Untitled: 204Untitled: 167Untitled: 163Untitled: 186 -
Simultaneous dual pathology in lymph node
1601PDF: 664HTML: 7673Simultaneous dual pathology in lymph node: 155Simultaneous dual pathology in lymph node: 152Simultaneous dual pathology in lymph node: 136Simultaneous dual pathology in lymph node: 168Simultaneous dual pathology in lymph node: 154 -
ALLOGENEIC TRANSPLANTATION FOR CHRONIC LYMPHOCYTIC LEUKEMIA
1309PDF: 728HTML: 930 -
NPM1 MUTATED, BCR-ABL1 POSITIVE MYELOID NEOPLASMS: REVIEW OF LITERATURE NPM1 mutated, BCR-ABL1 positive myeloid neoplasms
1518PDF: 1125HTML: 181 -
APPROACHING THE TARGET: THE PATH TOWARDS AN EFFECTIVE MALARIA VACCINE
2465PDF: 891HTML: 15064 -
DECREASED CD10 EXPRESSION IN THE BONE MARROW NEUTROPHILS OF HIV POSITIVE PATIENTS
1170PDF: 829HTML: 1092Coverletter: 172 -
TREATMENT OF ADVANCED SYSTEMIC MASTOCYTOSIS WITH MIDOSTAURIN: PRACTICAL GUIDANCE FOR OPTIMAL THERAPY AND MANAGEMENT Advanced systemic mastocytosis and midostaurin
1145PDF: 907HTML: 186 -
LYON-UNIVERSITY HOSPITAL EXPERIENCE WITH GEMTUZUMAB OZOGAMICIN THERAPY IN ACUTE MYELOID LEUKEMIA: A ‘REAL-LIFE’ STUDY Gemtuzumab ozogamicin in AML
1588PDF: 1114HTML: 227 -
PATHOGENESIS AND TREATMENT OF THROMBOHEMORRHAGIC DIATHESIS IN ACUTE PROMYELOCYTIC LEUKEMIA
1713PDF: 775HTML: 10200Figures 1,2,3: 150 -
CAR-T CELL THERAPY IN LARGE B CELL LYMPHOMA CAR-T; Large B Cell Lymphoma; Salvage Therapy,
3525PDF: 1357HTML: 166 -
Sorafenib induced Hand Foot Skin Rash in FLT3 ITD mutated Acute Myeloid leukemia- A case report and review of literature
1805PDF: 866HTML: 1738Sorafenib induced Hand Foot Skin Rash in FLT3 ITD mutated AML- IMAGES: 140 -
SHORT HISTORY OF MALARIA AND ITS ERADICATION IN ITALY
4539PDF: 1802HTML: 10992Fig 1: 197Fig 2: 153Fig 3: 272Fig 4: 152Fig 5: 143Fig 6: 151Fig 7: 159Fig 8: 147 -
IMMUNOLOGICAL EVOLUTION OF A COHORT OF HIV-2 INFECTED PATIENTS: PECULIARITIES OF AN UNDERESTIMATED INFECTION HIV-2 INFECTED PATIENTS PECULIARITIES
922PDF: 579HTML: 210 -
IMPORTANCE OF HYPERBILURUBINEMIA IN DIFFERENTIATION OF PRIMARY AND SECONDARY HEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS IN PEDIATRIC CASES
1726PDF: 909HTML: 1092Untitled: 136Untitled: 153Untitled: 139Untitled: 144 -
NOVEL MUTATIONS IN THE NON-STRUCTURE PROTEIN 2 OF SARS-CoV-2 Sequence analysis NSP2 of SARS-CoV-2
839PDF: 426HTML: 101







